Back to resultsEffectiveness of Using Interactive Consulting System to Enhance Decision Aids of COVID-19 Vaccination
Primary Purpose
COVID-19
Status
Recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Chatbot
Sponsored by
About this trial
This is an interventional health services research trial for COVID-19
Eligibility Criteria
Inclusion Criteria:
- Individuals aged over 18 years who have been resident in the selected study district for more than six months;
- Willing to participate the study and provide informed consent.
Exclusion Criteria:
- Having ocular, hearing or mental disorders precluding reading or telephone interview.
Sites / Locations
- Yingfeng Zheng, MD, PhDRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Interactive Q&A chatbot
Arm Description
A chatbot of patient decision aid embedded into a mobile application which is able to bidirectionally interact with patients and provide standard general information, quantitative risk information on the possible outcomes of COVID-19 vaccination.
Outcomes
Primary Outcome Measures
Informed choice about COVID-19 vaccination (the proportion of participants who make an informed choice，which is defined as a good knowledge score and an intention that is consistent with their attitude score)
Informed choice is an aggregated measure of multiple measurements, including knowledge (a 10-item questionnaire that assesses knowledge), attitudes (6 items, with 5 responses for each), and intentions (single item with 5 responses)
Secondary Outcome Measures
Full Information
NCT ID
NCT05087173
First Posted
October 20, 2021
Last Updated
January 16, 2023
Sponsor
Sun Yat-sen University
1. Study Identification
Unique Protocol Identification Number
NCT05087173
Brief Title
Effectiveness of Using Interactive Consulting System to Enhance Decision Aids of COVID-19 Vaccination
Official Title
Effectiveness of Using Interactive Consulting System to Enhance Decision Aids of COVID-19 Vaccination
Study Type
Interventional
2. Study Status
Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 11, 2021 (Actual)
Primary Completion Date
August 31, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Sun Yat-sen University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
To evaluate the performance of an interactive chatbot and assess its effectiveness for enhancing informed decisions made by cataract patients.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
COVID-19
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
1200 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Interactive Q&A chatbot
Arm Type
Experimental
Arm Description
A chatbot of patient decision aid embedded into a mobile application which is able to bidirectionally interact with patients and provide standard general information, quantitative risk information on the possible outcomes of COVID-19 vaccination.
Intervention Type
Device
Intervention Name(s)
Chatbot
Intervention Description
An interactive chatbot for patient decision aid A chatbot of patient decision aid embedded into a mobile application which is able to bidirectionally interact with patients and provide standard general information, quantitative risk information on the possible outcomes of COVID-19 vaccination.
Primary Outcome Measure Information:
Title
Informed choice about COVID-19 vaccination (the proportion of participants who make an informed choice，which is defined as a good knowledge score and an intention that is consistent with their attitude score)
Description
Informed choice is an aggregated measure of multiple measurements, including knowledge (a 10-item questionnaire that assesses knowledge), attitudes (6 items, with 5 responses for each), and intentions (single item with 5 responses)
Time Frame
2 weeks post intervention
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Individuals aged over 18 years who have been resident in the selected study district for more than six months;
Willing to participate the study and provide informed consent.
Exclusion Criteria:
Having ocular, hearing or mental disorders precluding reading or telephone interview.
Facility Information:
Facility Name
Yingfeng Zheng, MD, PhD
City
Guangzhou
State/Province
Guangdong
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yingfeng Zheng, MD, PhD
Phone
+8613922286455
Email
zhyfeng@mail.sysu.edu.cn
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Effectiveness of Using Interactive Consulting System to Enhance Decision Aids of COVID-19 Vaccination
We'll reach out to this number within 24 hrs